Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72611 record(s)

Req # A-2020-000172

Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_02985257.

Organization: Health Canada

6 page(s)
July 2020

Req # A-2020-000182

All documents in the Management of Executive Correspondence System (MECS) for the following file: 19-075631-61. Subject: Meeting with Innovative Medicines Canada.

Organization: Health Canada

11 page(s)
July 2020

Req # A-2020-000220

Adverse Reaction Report (AER) for JANUMET. Report numbers: 000654307, 000669449, 000670229, 000670331, 000672879, 000676798, 000679207.

Organization: Health Canada

11 page(s)
July 2020

Req # A-2020-000233

Adverse Reaction Report (AER) for PROSCAR. Report numbers: E2B_00338741, E2B_00367616.

Organization: Health Canada

23 page(s)
July 2020

Req # A-2020-000235

Adverse Reaction Report (AER) for SAPHRIS. Report numbers: 000665262, E2B_00504503, E2B_00842735, 000657185, E2B_00524529, E2B_00786552.

Organization: Health Canada

65 page(s)
July 2020

Req # A-2020-000253

Adverse Reaction Report (AER) for LEFLUNOMIDE. Report numbers: E2B_02783236, E2B_02783256, E2B_02786522, E2B_02787376, E2B_02777903, E2B_02794499, E2B_02778190, E2B_02669379, E2B_02779434, E2B_02781703, E2B_02815602, E2B_02781958, E2B_02775064,…

Organization: Health Canada

499 page(s)
July 2020

Req # A-2020-000303

Adverse Reaction Report (AER). Report numbers: E2B_02635786, E2B_02736735, E2B_02742363, E2B_02742392, E2B_02743143, E2B_02743448, E2B_02743460, E2B_02745793, E2B_02745796, E2B_02745799, E2B_02745809.

Organization: Health Canada

115 page(s)
July 2020

Req # A-2020-000310

Adverse Reaction Report (AER). Report number: 000718930.

Organization: Health Canada

1 page(s)
July 2020

Req # A-2020-000324

Adverse Reaction Report (AER) for Intuniv XR. Report number: 000732758.

Organization: Health Canada

1 page(s)
July 2020

Req # A-2020-000327

Adverse Reaction Report (AER) for Mesalazine. Report numbers: E2B_02818518, E2B_02871990, E2B_02903320, E2B_02903659.

Organization: Health Canada

43 page(s)
July 2020
Date modified: